President William L. Henrich, M.D., MACP, UT Health San Antonio

Santikos Suite offers capability to study Alzheimer’s, other diseases

October 5, 2017

William L. Henrich, M.D., MACP, president of UT Health San Antonio, recognized the John L. Santikos Charitable Foundation, a fund of the San Antonio Area Foundation, on Oct. 2 for its $2.3 million gift to build the John L. Santikos CT and Nuclear Medicine Suite at the university. The state-of-the-art imaging suite is on the […]

Read more

Express-News: Childhood cancer needs more attention

October 2, 2017

The following appeared in the San Antonio Express-News on Sept. 24. The author is Gregory J. Aune, M.D., Ph.D., assistant professor of pediatrics at the Greehey Children’s Cancer Research Institute. September is Childhood Cancer Awareness Month. Many citizens in our community may not realize that San Antonio is home to the Greehey Children’s Cancer Research […]

Read more

Erase Cancer

Greehey Institute contributes to survey of RAS-sensing antibodies

September 28, 2017

Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio are co-authors on a paper published Sept. 26 in Science Signaling, a high-impact journal that is part of the Science family of journals. RAS mutations are implicated in several cancers, including lung, colorectal and pancreatic ductal carcinoma. The three RAS genes are […]

Read more

University President William L. Henrich, M.D., MACP, and Ruben A. Mesa, M.D.,

New cancer center director welcomed

September 14, 2017

A reception honoring new UT Health Cancer Center Director Ruben A. Mesa, M.D., was held Sept. 14. Dr. Mesa began his post in August. The event was hosted by President William L. Henrich, M.D., MACP; Ron Rodriguez, M.D., Ph.D., interim dean of the Joe R. & Teresa Lozano Long School of Medicine; and Department of […]

Read more

Rui Sousa, Ph.D., UT Health San Antonio

UT Health team finds way to measure key cell regulator’s activity

September 5, 2017

UT Health San Antonio researchers and co-authors in New York state on Monday (Sept. 4) reported an innovative approach that will enable scientists to study the most common regulator of our bodies’ cells, a molecule called guanosine-5′-triphosphate (GTP). Nature Methods, the world’s most prestigious journal for reporting novel biomedical technologies, published the team’s findings. The […]

Read more

H-E-B joins UT institutions to raise money for cancer patients

August 23, 2017

H-E-B is launching a fundraising campaign with The University of Texas MD Anderson Cancer Center to help create a future free from cancer.

Read more